SCHEMBL30628201

SCHEMBL30628201

CC(C)Oc1cc(F)ccc1C(F)(F)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.41
▸ RXRB P28702 1/20 0.41
▸ RXRG P48443 1/20 0.41
▸ KCNK3 O14649 1/20 0.40
▸ KCNK9 Q9NPC2 1/20 0.40
▸ PPARG P37231 1/20 0.40
▸ P2RX7 Q99572 1/20 0.38
▸ IRAK4 Q9NWZ3 1/20 0.37
▸ MKNK1 Q9BUB5 2/20 0.37
▸ MKNK2 Q9HBH9 2/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ EIF4E P06730 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17420649 1.00 RXRA (0.41) RXRARXRBRXRGKCNK3KCNK9
SCHEMBL30087653 0.87 IRAK4 (0.43) RXRARXRBRXRGKCNK3KCNK9
SCHEMBL29099261 0.84 PPARG (0.39) PPARGL3MBTL1
SCHEMBL17420685 0.83 PPARG (0.49) RXRARXRBRXRGKCNK3KCNK9
SCHEMBL30628295 0.83 PPARG (0.49) RXRARXRBRXRGKCNK3KCNK9
SCHEMBL17420436 0.82 MAPT (0.41) RXRARXRBRXRGKCNK3KCNK9
SCHEMBL17420667 0.81 EPHX2 (0.44) RXRARXRBRXRGKCNK3KCNK9
SCHEMBL30628189 0.81 EPHX2 (0.44) RXRARXRBRXRGKCNK3KCNK9
SCHEMBL24176727 0.80 DRD2 (0.45) RXRARXRBRXRGKCNK3KCNK9
SCHEMBL17420416 0.79 RXRA (0.42) RXRARXRBRXRGKCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111170991-B Antiproliferative compounds and methods of synthesis thereof 细胞基因公司 2023-10-31 — — CN disclosed
Send feedback